Ionis Pharmaceuticals Inc (NASDAQ: IONS): Reassessing Prospects

Fidelity Management & Research Co has recently announced that it has increased stake in Ionis Pharmaceuticals Inc (NASDAQ:IONS) by 0.16%. After grabbing 21.5 million shares, the institutional investor is now in possession of 35106.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 15.00% having worth around $951.76 million. […]